TVTX - Company ID 0001438533
As of 2026-07-09, Travere Therapeutics, Inc. (TVTX) has a market capitalization of $5.44 B, making it the #1355 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-07-09 | $5.44 B |
| 2026-07-08 | $5.38 B |
| 2026-07-07 | $5.44 B |
| 2026-07-06 | $5.35 B |
| 2026-07-05 | $5.29 B |
| 2026-07-04 | $5.29 B |
| 2026-07-03 | $5.29 B |
| 2026-07-02 | $5.29 B |
| 2026-07-01 | $5.25 B |
| 2026-06-30 | $5.32 B |
| 2026-06-29 | $5.42 B |
| 2026-06-28 | $5.47 B |
As of 2026-07-09, Travere Therapeutics, Inc. (TVTX) has a market capitalization of $5.44 B, making it the #1355 most valuable US-listed company.
Travere Therapeutics, Inc. is the #1355 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-06-27 | $5.47 B |
| 2026-06-26 | $5.47 B |
| 2026-06-25 | $5.49 B |
| 2026-06-24 | $5.37 B |
| 2026-06-23 | $5.20 B |
| 2026-06-22 | $5.12 B |
| 2026-06-21 | $5.13 B |
| 2026-06-20 | $5.13 B |
| 2026-06-19 | $5.13 B |
| 2026-06-18 | $5.04 B |
| 2026-06-17 | $5.03 B |
| 2026-06-16 | $4.93 B |
| 2026-06-15 | $4.98 B |
| 2026-06-14 | $4.84 B |
| 2026-06-13 | $4.84 B |
| 2026-06-12 | $4.82 B |
| 2026-06-11 | $4.47 B |
| 2026-06-10 | $4.35 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.